Speech-Language Pathologists in Durand, IL Accepting Medicare
2 Speech-Language Pathologists found. Showing 1 - 2
 Ms. Amy Joan Uebelhoer, M.S.CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 402 Center St, Durand, IL 61024 Phone: 815-248-2151 Fax: 815-248-2771 |
Kiley Beck, CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 200 W South St, Durand, IL 61024 Phone: 815-248-2171 |
News Archive
Study findings suggest how progranulin deficiency causes frontotemporal dementia
In a recent study in Human Molecular Genetics, researchers from VIB and KU Leuven led by prof. Philip Van Damme, reveal a novel function for progranulin in lysosomes: it acts as chaperone of the lysosomal protease cathepsin D. The results were obtained in collaboration with Prof. Paul Saftig from the University of Kiel.
Georgia State professor receives five-year $4.1 million federal grant to develop drug targeting Ebola virus
Dr. Christopher Basler, a professor in the Institute for Biomedical Sciences at Georgia State University, director of the university's Center for Microbial Pathogenesis and a Georgia Research Alliance Eminent Scholar in Microbial Pathogenesis, has received a five-year, $4.1 million federal grant to develop a drug targeting Ebola virus.
Scientists develop new micropump for hand-held medical devices
In an advance toward analyzing blood and urine instantly at a patient's bedside instead of waiting for results from a central laboratory, scientists are reporting development of a new micropump capable of producing pressures almost 500 times higher than the pressure in a car tire. Described in ACS' journal Analytical Chemistry, the pumps are for futuristic "labs-on-a-chip," which reduce entire laboratories to the size of a postage stamp.
Animal studies reveal brain changes responsible for appetite effects of cannabis
New research on how cannabis use alters eating behavior could lead to treatments for appetite loss in chronic illness, according to experts at Washington State University.
New understanding of how immune-based therapies can treat Alzheimer's disease
Researchers at Weill Cornell Medical College have gotten much closer to understanding how immune-based therapies can treat Alzheimer's disease - by studying how antibodies go inside brain cells to reduce levels of Alzheimer's-linked amyloid peptides that form plaques between neurons.
› Verified 8 days ago